- 02:52 AM Mahindra arm to bid for USD 3.5bn defence deals
- 09:30 PM Positive global cues, RIL power markets
- 09:19 PM Hindalco launches $600m QIP book at Rs 130.9/s...
- 09:00 PM After per second billing, what next for telecom?
- 08:53 PM Prestige Group ramps up investment plans
- 08:35 PM Property prices likely to go up in December
- 07:55 PM Mahindra arm to bid for $3.5 bn defence deals
- 07:26 PM Tech Toyz celebrates the waning of recession
- 07:23 PM Experts see mkts at new highs, advise sectors
- 07:21 PM HCL Tech bags $200m order from UK’s Equitable ...



New Delhi: A paralysed Australian woman, Sonya Smith, underwent a controversial new stem cell treatment in India, and has defied doctors by walking again.
Sonya was paralysed after being crushed by the wheels of her own car. Eighteen months doctors announced that she was a paraplegic, with no feeling below her waist and with no control over her bowel and bladder. Doctors had said her condition would remain like that forever.
However, she underwent pioneering injections of embryonic stem cells and after eight weeks of the treatment in Delhi - treatment that was deemed controversial - Sonya is walking again with the aid of calipers and is beginning to get the sensation back in her legs.
"Everyone that I have spoken to said that I wouldn't get any feeling or any movement back, even my mother, who from day one has constantly tried to get my head around to accept the fact that this was how I was going to be for the rest of my life," says she.
Dr Geeta Shroff, who treated Sonya, has not outlined her methods to her medical colleagues outside India. Though concerns remain that the treatment is still unproven and unreliable, Dr Shroff remains convinced it's a huge medical breakthrough.
"It's so huge. I mean, for a person who cannot walk to start walking, whether it's with support or not, a person who has no bladder and bowel, to get that again - medically it's huge," Dr Shroff told Sky.
As of now, the medical treatment is being patented and will then become available for medical practitioners to judge whether it works or not.
Source: CNN-IBN
Picture is representative and not of the patient
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- Corrections in '10 to be more aggressive, violent: JPMorgan

- 10 companies that MF managers love
- Bollywood actress Shilpa Shetty marries Raj Kundra
- Ignore Buffett, gold`s time has come
- LyondellBasell development positive for RIL: PN Vijay

- Accumulate Bharti Airtel: Phani Sekhar

- Ganeshaspeaks: Market prediction for Nov 23
- Positive global cues, RIL power markets
Source: CNBC-TV18
- Hindalco launches $600m QIP book at Rs 130.9/sh
Source: CNBC-TV18
- Telecom woes: Lower tariffs, consolidation seen ahead
Source: CNBC-TV18
- Prestige Group ramps up investment plans
Source: CNBC-TV18
- China`s Haitong Securities buys Hong Kong rival
Source: ft.com
- KSIDC in pact with FACT for trade centre
Source: Business Line
- GIC Re may have to pay Rs100cr for IOC's Jaipur fire claims
Source: Business Line
- Co-operative dairies seek restraint on oil-meal exports
Source: Business Line






















